Summary:
A randomized double-blind, placebo-controlled, multicenter
study to evaluate the efficacy, safety and tolerability of
An investigational product in US Black/African American &
Hispanic patient populations with elevated Lp(a) and
established atherosclerotic cardiovascular disease
Qualified Participants Must:
• Have established history of heart disease
•
Be Black American or Hispanic American
•
Be 18-79 years old
Qualified Participants May Receive:
Testing for Lp(a), which tells if genetically you are at high risk for having another cardiovascular event
other safety labs
physical exams
Investigational product that may reduce risk of another event
nosotros hablamos espanol aqui